Cyclopentamine
| |
| Cyclopentamine
| |
| Systematic (IUPAC) name | |
| 1-cyclopentyl-N-methyl-propan-2-amine | |
| Identifiers | |
| CAS number | |
| ATC code | R01 |
| PubChem | |
| Chemical data | |
| Formula | C9H19N |
| Mol. mass | 141.254 |
| Physical data | |
| Boiling point | 171 °C (340 °F) |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
?(US) |
| Routes | ? |
|
WikiDoc Resources for Cyclopentamine | |
|
Articles | |
|---|---|
|
Most recent articles on Cyclopentamine Most cited articles on Cyclopentamine | |
|
Media | |
|
Powerpoint slides on Cyclopentamine | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Cyclopentamine at Clinical Trials.gov Trial results on Cyclopentamine Clinical Trials on Cyclopentamine at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Cyclopentamine NICE Guidance on Cyclopentamine
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Cyclopentamine Discussion groups on Cyclopentamine Patient Handouts on Cyclopentamine Directions to Hospitals Treating Cyclopentamine Risk calculators and risk factors for Cyclopentamine
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Cyclopentamine | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Cyclopentamine is a stimulant drug structurally related to methamphetamine, wherein the aromatic phenyl ring is replaced with a cyclopentane ring. Due to its strong vasoconstricting properties, cyclopentamine is typically found in over-the-counter nasal decongestant swabs. When ingested in sufficient quantities, it produces effects similar to amphetamine. Cyclopentamine-containing products are primarily marketed and distributed in Europe. It is not currently listed as a controlled substance in the United States.
See also
Decongestants and other nasal preparations (R01) | |
|---|---|
| Topical: sympathomimetics, plain | Cyclopentamine - Ephedrine - Phenylephrine - Oxymetazoline - Tetryzoline - Xylometazoline - Naphazoline - Tramazoline - Metizoline - Tuaminoheptane - Fenoxazoline - Tymazoline - Epinephrine |
| Topical: antiallergic agents, excluding corticosteroids | Cromoglicic acid - Levocabastine - Azelastine - Antazoline - Spaglumic acid - Thonzylamine - Nedocromil - Olopatadine |
| Topical: corticosteroids | Beclometasone - Prednisolone - Dexamethasone - Flunisolide - Budesonide - Betamethasone - Tixocortol - Fluticasone - Mometasone furoate - Triamcinolone - Ciclesonide |
| Topical: other nasal preparations | Calcium hexamine thiocyanate - Retinol - Ipratropium bromide - Ritiometan - Mupirocin - Hexamidine - Framycetin |
| Systemic use: Sympathomimetics | Phenylpropanolamine - Pseudoephedrine - Phenylephrine |
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
